Dechert (Paris)

Mélanie Thill-Tayara

Dechert (Paris)
Partner

Mélanie Thill-Tayara is a partner in Dechert’s Paris office and co-lead of the firm’s Life Sciences practice. Mélanie focuses her practice on antitrust and competition law, and she regularly represents leading companies in cartel and abuse of dominant position cases before EU and French authorities and courts. In addition, Mélanie assists leading companies in merger notifications before the French and European regulators and coordinates multi-jurisdictional filings. She regularly advises clients involved in inspections conducted by the authorities and the subsequent challenges. Prior to joining Dechert in February 2016, she served as a partner for more than 20 years with two other international law firms. Before that, she was an officer at the European Commission, Directorate-General for Competition, where she participated in numerous dawn raid operations and contributed to several decisions. Named Top Woman in Antitrust (GCR Women in Antitrust), Mélanie Thill-Tayara is ranked as one of the top competition and antitrust lawyers in France by Chambers Europe, Legal 500, GCR100, Who’s Who Legal : France and Best Lawyers France 2022.

Distinctions

Linked authors

Dechert (Paris)
Dechert (Chicago)
Dechert (London)
Dechert (Moscow)
Dechert (London)

39647 | Events

Videos

Mélanie Thill-Tayara (Dechert)
Mélanie Thill-Tayara 30 November 2018 Paris
Mélanie Thill-Tayara (Dechert)
Mélanie Thill-Tayara 30 November 2018 Paris
Mélanie Thill-Tayara - Global Merger Control Conference - 2 December 2016
Mélanie Thill-Tayara 2 December 2016 Paris

Articles

8317 Bulletin

Mélanie Thill-Tayara, Marion Provost The French Supreme Court rejects an appeal by a pharmaceutical company which alleged that a €21M fine imposed by the competition authority was erroneous (Janssen-Cilag)

60

On 1 June 2022, the French Supreme Court (the “Supreme Court”) entirely dismissed the appeal of Janssen-Cilag (“Janssen”) and its parent company Johnson & Johnson against a judgment of the Paris Court of Appeal (the “Court of Appeal”) of 11 July 2019 in the Durogesic® case. However, this ruling (...)

Mélanie Thill-Tayara, Laurence Bary, Marion Provost The EU Commission adopts the new Vertical Block Exemption Regulation and Vertical Guidelines signalling cautiousness around information exchange in dual distribution situations

22

On 10 May 2022, the European Commission (the “Commission”) adopted the final version of the new Vertical Block Exemption Regulation (“VBER”), which will enter into force on 1 June 2022. The new VBER, which replaces Regulation No. 330/2010 of 20 April 2010, is accompanied by a new version of the (...)

Mélanie Thill-Tayara, Marion Provost, Sophie Mitouard Dominance in the pharmaceutical sector: An overview of EU and national case law

1118

In a communication of November 2020, the European Commission presented its ‘new Pharmaceutical Strategy for Europe’, the main objective of which is to achieve a strong, fair, competitive, and green pharmaceutical industry, centered on patients’ needs. The Commission’s ambition is to remove existing barriers that prevent patients’ access to innovative and affordable medicines, while facilitating the digital transformation of the industry. In this context, the enforcement of competition rules certainly remains an important instrument for the Commission to achieve its goals and we expect the sector to remain a key priority throughout the European Union. Just in the past year, several important decisions have been adopted and multiple investigations opened, both in antitrust and merger control.

Christophe De Vienne, Mélanie Thill-Tayara, Laurence Bary The EU Court of Justice declares that financial investors are liable for anti-competitive conduct of portfolio companies (Goldman Sachs)

182

The European Court of Justice has confirmed that financial investors can incur parental liability for the anticompetitive practices of portfolio companies, even after an IPO that left the investor holding only a minority stake in the company, provided that they still have sufficient (...)

Mélanie Thill-Tayara, Laurence Bary, Marion Provost The EU Court of Justice confirms that financial investors can incur parental liability for the anticompetitive practices of their portfolio companies (Goldman Sachs)

29

This article has been nominated for the 2021 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. The European Court of Justice has confirmed that financial investors can incur parental liability for the anticompetitive practices of portfolio companies, even (...)

Mélanie Thill-Tayara, Laure Arnaud, Marion Provost The EU General Court partially annuls the Commission’s decision authorizing unannounced dawn raids to be carried out at the headquarters of two French food retail chains (Casino, Guichard-Perrachon / Achats Marchandises Casino) (Intermarché Casino Achats) (Les Mousquetaires / ITM Entreprises)

217

In three recent judgments issued on 5 October 2020, the General Court of the European Union ("GCEU") partially annulled the European Commission’s ("Commission") decisions of February 2017 which had authorized onsite unannounced inspections ("dawn raid”) to be carried out at the headquarters of (...)

Laurence Bary, Alec J. Burnside, Mélanie Thill-Tayara, Clemens York von Wartenburg The European Competition Network issues a general joint statement on the application of competition rules during the COVID-19 outbreak

503

Key Takeaways Following several individual initiatives by member state competition authorities to temporarily relax competition rules in specific sectors, the European Competition Network (which includes the European Commission and all member state competition authorities) has issued a more (...)

Mélanie Thill-Tayara, Marion Provost The Paris Court of Appeal clarifies the relevant test for characterizing an excessive price in the market of waste disposal for hospitals and clinics in Corsica (Sanicorse)

158

On 14 November 2019, the Paris Court of Appeal (the “Court”) quashed a decision of the French Competition Authority (“FCA”) of 20 September 2018 in which the latter had imposed € 199 000 fine on Sanicorse for having abused its dominant position on the market for infectious clinical waste (“ICW”) (...)

Mélanie Thill-Tayara, Marion Provost, Sophie Mitouard The Paris Court of Appeal upholds the decision of the Competition Authority to fine a pharma company for abuse of dominance (Jansson-Cilag / Johnson & Johnson)

131

More particularly, the Court affirmed the FCA’s conclusion that Janssen infringed competition law by, on the one hand, disparaging competing fentanyl specialties towards health professionals, emphasizing the risks associated with a switch from Durogesic© to a generic version and, on the other (...)

Marion Provost, Mélanie Thill-Tayara, Simon Hetsch, Sophie Pelé The EU General Court annuls a decision of the Commission for wrongly qualifying agreements as "pay for delay" and improperly qualifying an abuse of dominance, thus reducing the fine imposed on a pharmaceutical company (Servier)

540

The General Court annuls in part the European Commission’s decision finding the existence of restrictive agreements and an abuse of a dominant position on the market for perindopril, a medicine used to treat hypertension and heart failure* On 12 December 2018, the General Court (“Court”) (...)

Alec J. Burnside, Clemens York von Wartenburg, Laurence Bary, Mélanie Thill-Tayara The EU General Court finds financial investors liable for anticompetitive conduct of portfolio companies over which they hold decisive influence (Goldman Sachs)

167

The General Court of the European Union recently held, in Goldman Sachs v. Commission, that purely financial investors such as investment funds may be held jointly and severally liable for competition law violations implemented by their portfolio companies when they can exercise “decisive (...)

Alec J. Burnside, Anne MacGregor, Mélanie Thill-Tayara, Romain Maulin The EU Court of Justice orders new assessment in a case of abuse of dominance by a semi-conductor company granting loyalty rebates (Intel)

251

EU Court Orders New Assessment of Intel’s Rebates The Court of Justice of the European Union (CJEU) has quashed a ruling by the EU’s General Court which had upheld the European Commission’s (EC) 2009 finding of abuse of dominance by Intel Corporation Inc. Intel was fined €1.06 billion, a record at (...)

9954 Review

Franck Audran, Martine Behar-Touchais, Frédéric Buy, Walid Chaiehloudj, Antoine Choffel, Sophie Harnay, Stéphane de La Rosa, Sophie Pelé, Marion Provost, Mélanie Thill-Tayara Emmanuel Macron, as Minister and President: a rather positive competitive record in competition law

3851

What is the competition balance sheet of Emmanuel Macron, Minister of the Economy and then President of the Republic? It is remarkable that Emmanuel Macron had a very strong reforming will in competition and distribution law, by opening markets (regulated professions, bus transport, rail (...)

Mélanie Thill-Tayara, Stanislas Martin Stanislas Martin (French Competition Authority): Which balance between the effectiveness of competition procedures and the rights of defense?

1238

Interview conducted by Mélanie Thill-Tayara, Partner, Dechert, Paris. A graduate of the Institut d’Etudes Politiques de Paris and ENA, you have held several positions within the DGCCRF, worked for the Permanent Representation of France to the European Union and, less conventionally, practiced (...)

Andreas Mundt, Bruno Lasserre, Mélanie Thill-Tayara, Peter Freeman, Wouter Wils European Competition Network & EC Regulation 1/2003 10 years after: Can cooperation be extended to merger control and advocacy? (New Frontiers of Antitrust, Paris, 21 February 2014)

886

This third roundtable of the conference “New frontiers of Antitrust” (Paris, 21 February 2014) was dedicated to “European Competition Network 10 years after & EC Regulation 1/2003: Can cooperation be extended to merger control and advocacy?”. The objectives for the authors of this roundtable (...)

Books

Send a message